How to reduce review fatigue in pharmaceutical documentation

Document review is supposed to improve quality. When the process becomes overloaded, it can do the opposite.

Pharmaceutical teams may have the same SOP reviewed by six or eight people, receive hundreds of comments across several rounds and spend weeks resolving wording that does not change the underlying process. Reviewers become less attentive, authors struggle to separate critical issues from preferences and important risks can disappear inside comment volume.

This is review fatigue.

Reducing review fatigue does not mean reducing control. It means designing pharmaceutical documentation review so that the right people review the right issues, at the right level of depth, with enough context to make useful decisions.

Review fatigue is usually a workflow problem

Review fatigue is often treated as a people problem: reviewers are too busy, authors need to be more careful or SMEs need to respond faster.

Those factors can matter, but repeated fatigue usually points to a weak review model.

If every document follows the same approval path regardless of risk, every reviewer comments on every topic and the first draft enters formal review before the process is stable, the organization creates unnecessary review work by design.

Common causes include

• Too many reviewers.
• Unclear reviewer responsibilities.
• Poor first drafts.
• Unresolved process decisions.
• Large documents sent as one review package.
• No distinction between critical comments and stylistic preferences.
• Repeated review of unchanged sections.
• Conflicting SME comments.
• Late terminology changes.
• No clear owner for resolving disagreements.

A better process removes avoidable review work before asking people to spend more time reviewing.

Organizations that need help redesigning documentation workflows can use Bárd Global’s knowledge management and documentation consulting to examine ownership, review roles, content dependencies and governance together.

Use risk to decide how much review is needed

Not every pharmaceutical document needs the same review intensity.

ICH Q9(R1) states that the level of effort, formality and documentation applied to quality risk management should be commensurate with risk. The same principle can help teams think more clearly about review effort.

A high-risk manufacturing SOP, a minor editorial correction and a low-risk internal reference document should not automatically receive identical review depth.

Review depth can consider

• Impact on product quality.
• Impact on patient safety.
• Whether the document controls a critical process.
• Whether the change affects regulated commitments.
• Complexity of the process.
• Extent of the revision.
• Number of downstream documents affected.
• Whether the content is new or already established.

Risk-based review helps preserve rigor where it matters while avoiding unnecessary formality for lower-risk changes.

Define reviewer roles before the document enters review

Review slows down when everyone feels responsible for everything.

A manufacturing SME may rewrite sentences for style. A quality reviewer may recheck technical details already confirmed by engineering. A senior manager may comment on formatting instead of the decision they were asked to approve.

Clear review roles reduce duplication.

A review model might separate

• Process owner: confirms the procedure reflects the approved process.
• Technical SME: confirms scientific, engineering or specialist accuracy.
• Document owner: checks scope, structure, dependencies and document consistency.
• Quality reviewer: checks required controls and alignment with the quality system.
• Regulatory reviewer: assesses regulatory implications where applicable.
• Final approver: confirms the document is ready for controlled use.

Not every document needs every role. The reviewer list should reflect the content and risk.

Give reviewers a defined review question

A request that says “please review” is too broad.

It invites every reviewer to comment on anything they notice, including issues outside their expertise or responsibility.

A focused request tells each reviewer what decision they are being asked to make.

Examples include

• Confirm that the process sequence is technically correct.
• Confirm that responsibilities match the approved operating model.
• Check that the validation references are current.
• Confirm that the change is consistent with the quality system.
• Review only sections 4 and 6 because all other sections are unchanged.
• Confirm that the terminology matches the approved glossary.

Specific review questions make comments easier to evaluate and reduce repetitive editing.

Do not use formal review to discover the process

Some review cycles become long because the organization is still deciding how the process should work.

The draft SOP becomes a discussion document, and every review round introduces another operational decision.

That is expensive because writers repeatedly restructure content that was never ready for controlled review.

Before formal review, confirm

• The process is agreed.
• Roles and responsibilities are clear.
• Systems and forms are known.
• Major exceptions are defined.
• Required terminology is established.
• The source information is authoritative.
• Known disagreements have been escalated.

Drafting can help expose process gaps, but those gaps should be resolved before the document enters the main approval cycle.

Improve the first draft before adding reviewers

A weak first draft multiplies review workload.

Reviewers spend time fixing structure, repeated terminology, missing references and inconsistent formatting before they can focus on technical accuracy.

A pre-review quality check can remove much of that noise.

Before formal review, check

• Scope and purpose.
• Heading structure.
• Role names.
• Terminology.
• Document references.
• Version numbers.
• Form and system names.
• Defined abbreviations.
• Formatting and template compliance.
• Obvious grammar or readability issues.

Where teams need additional drafting or remediation capacity, Bárd Global’s technical writing services can improve draft quality before documents reach internal SMEs and approvers.

Separate critical comments from preferences

Not every review comment has the same importance.

If a safety issue, a missing process step and a preferred wording change all appear in one undifferentiated comment list, authors spend time treating them as equivalent.

A simple comment classification can improve prioritization.

For example

• Critical: could affect quality, safety, compliance or correct process execution.
• Major: materially affects technical accuracy, clarity or consistency.
• Minor: useful correction that does not change meaning.
• Preference: stylistic option with no material effect on accuracy or usability.
• Question: requires clarification before a decision can be made.

Organizations do not need to use these exact labels, but they should distinguish material issues from optional editorial preferences.

Set rules for stylistic comments

Stylistic comments are one of the largest sources of avoidable review volume.

One reviewer prefers “ensure,” another prefers “verify,” and a third rewrites the sentence back to something close to the original.

A style guide and controlled terminology reduce those cycles.

Standardize

• Preferred terminology.
• Role titles.
• Capitalization.
• Abbreviations.
• Procedure-step style.
• Warnings and notes.
• Cross-reference format.
• Common document language.

Once the organization has agreed these conventions, reviewers should not repeatedly reopen them unless context genuinely requires an exception.

Use controlled vocabulary to reduce terminology debate

Terminology disputes consume review time because they often repeat across documents.

If a team debates the same product name, process label or quality term every time it appears, the problem belongs in terminology governance rather than document review.

Approved controlled vocabulary gives reviewers a shared reference.

A terminology record can show

• Preferred term.
• Definition.
• Approved abbreviation.
• Accepted synonym.
• Deprecated term.
• Owner.
• Applicable context.

This moves recurring language decisions out of individual review cycles.

Review changed sections, not the entire document by default

A small revision does not always justify rereading a 40-page SOP from beginning to end.

Where the quality system permits and dependencies are understood, reviewers can focus on changed sections and any content that the change may affect.

A clear change summary makes that possible.

A useful change summary should explain

• What changed.
• Why it changed.
• Which sections were revised.
• Which related documents were assessed.
• Whether training impact was identified.
• Whether terminology or responsibilities changed.
• Any sections that require special reviewer attention.

The document owner still needs to assess whether a local change creates wider consequences before limiting review scope.

Break large review packages into logical units

Review quality falls when people receive a large package and are expected to return detailed comments quickly.

Long documents can be split into logical sections or reviewed in stages where the workflow allows it.

This is especially useful for new procedures, complex technical documentation or large remediation projects.

A staged review might separate

• Process structure.
• Technical content.
• Forms and records.
• Quality controls.
• Implementation and training impacts.
• Final integrated document.

Early structural review prevents teams from polishing sections that may later be reorganized.

Control comment resolution

Comments become exhausting when several reviewers raise conflicting instructions and the author is expected to resolve them alone.

There should be a defined escalation path for disagreement.

The document owner or process owner should have authority to bring the right people together and close the issue.

A controlled comment process can define

• Who consolidates comments.
• Who decides when two comments conflict.
• Which comments require formal response.
• How rejected comments are documented where necessary.
• When a live review meeting is more efficient than another comment round.
• Who decides that the document is ready for approval.

Endless asynchronous comments are rarely the best way to solve a genuine technical disagreement.

A hypothetical manufacturing SOP example

Consider a hypothetical pharmaceutical manufacturer revising an equipment-cleaning SOP.

Seven reviewers receive the full document. The change affects only cleaning-agent concentration, one verification step and the associated form, yet reviewers comment across the entire SOP.

The next revision includes more than 120 comments, most of which relate to wording and formatting outside the changed sections.

A better approach would provide a change summary, direct technical reviewers to the affected process steps, ask Quality to assess control impact and route terminology questions through an approved glossary.

The review remains controlled, but the effort is concentrated on the actual risk.

A hypothetical quality-system example

Imagine a hypothetical life sciences company replacing its deviation-management system.

Several SOPs need screenshots and workflow steps updated. During review, SMEs repeatedly debate field labels that are already fixed by the validated system.

The document owner separates system-controlled terminology from editable procedure language and provides reviewers with the approved interface terms.

Review comments become more focused because reviewers no longer spend time proposing language the system itself cannot change.

Use meetings selectively

Meetings can either reduce review fatigue or add another layer of it.

They are useful when a small number of unresolved issues require a decision from several functions.

They are less useful when participants read the document together line by line.

Use a review meeting when

• Comments conflict.
• A process decision is unresolved.
• Several documents depend on the same decision.
• A terminology issue affects multiple functions.
• The same topic has survived more than one review round.

Send the open decisions before the meeting and record the outcomes afterward.

Set review deadlines that match complexity

Unrealistically short review windows encourage superficial approval or rushed comments.

Very long windows can be equally damaging because reviewers repeatedly postpone the work and then reorient themselves each time they return to it.

Review timing should reflect document length, risk and the reviewer task.

A useful review request includes

• Document purpose.
• Reason for review.
• Specific sections to review.
• Reviewer responsibility.
• Due date.
• Known high-risk issues.
• Link to the controlled draft.
• Instructions for submitting comments.

Measure review quality, not only review speed

A short review cycle is not automatically a good one.

If documents return for repeated correction after approval or reviewers routinely miss important dependencies, speed may be hiding weak review quality.

Measures should examine both efficiency and effectiveness.

Useful indicators include

• Number of review rounds.
• Average comments per document.
• Percentage of comments classified as material versus preference.
• Time spent resolving conflicting comments.
• Number of late reviewer additions.
• Post-approval corrections linked to missed review issues.
• Documents returned because source information was incomplete.

Patterns in these measures can show whether the bottleneck is drafting, reviewer selection, governance or source quality.

Use AI for mechanical review, not regulated judgment

AI and automated tools can reduce low-value review work when used carefully.

They can identify repeated terminology, broken cross-references, inconsistent formatting, duplicate text or potential readability issues before a controlled reviewer sees the document.

They should not replace qualified judgment on regulated, scientific or quality decisions.

AI-assisted checks can help identify

• Terminology inconsistency.
• Undefined abbreviations.
• Potential duplicate sections.
• Missing referenced headings.
• Formatting differences.
• Long or unclear sentences.
• Possible mismatch with an approved style guide.

Any automated output should be validated through appropriate human review before it influences controlled content.

Bárd Global’s guidance on technical writing with AI explains why strong source content, governance and human validation remain important when AI is used in documentation workflows.

A practical workflow for reducing review fatigue

Use this sequence

1. Assess document risk. Decide how much review formality and depth the content actually needs.
2. Stabilize the process. Resolve operational decisions before formal document review.
3. Improve the draft. Remove structural, terminology and formatting noise first.
4. Select only necessary reviewers. Match reviewers to the risks and decisions in the document.
5. Give each reviewer a defined question. Clarify what they are expected to confirm.
6. Provide a change summary. Show what changed and where attention is needed.
7. Classify comments. Separate critical issues from minor corrections and preferences.
8. Resolve conflicts quickly. Escalate genuine disagreements instead of repeating comment rounds.
9. Use tools for mechanical checks. Remove low-value errors before human review.
10. Measure the process. Track where review rounds, comments and delays are coming from.

How Bárd Global supports pharmaceutical document review

Bárd Global works with life sciences and other complex organizations where documentation review consumes significant SME, quality and operational capacity.

Support can include document remediation, technical writing, review-workflow design, controlled vocabulary, ownership clarification, documentation audits, backlog reduction and preparation of content for AI-supported workflows.

Bárd works directly with internal SMEs and quality teams so external documentation support removes avoidable workload without replacing the regulated decisions and approvals that belong inside the organization.

With more than 25 years of experience, Bárd Global can support a focused remediation program or additional documentation capacity across a larger regulated content estate.

If your reviewers are spending too much time on repeated edits, conflicting comments or documents that were not ready for review, talk to the Bárd Global team. We can help identify which parts of the review workflow are creating unnecessary load.

Frequently asked questions

What causes review fatigue in pharmaceutical documentation?

Review fatigue usually develops when too many people review the same document, reviewer responsibilities are unclear or documents enter review before the underlying process is stable.

Repeated stylistic comments, conflicting SME feedback and large review packages can add further load.

The issue is often the workflow rather than the willingness of reviewers to participate.

A clearer review model can reduce volume while preserving appropriate control.

How can pharmaceutical companies reduce document review cycles?

Improve the draft before formal review, limit the reviewer list to people with a defined responsibility and provide a clear change summary.

Reviewers should know which sections and decisions require their attention.

Terminology and style questions should be governed centrally where possible instead of being reopened in every document.

Genuine disagreements should be escalated quickly rather than carried into another full review round.

Who should review pharmaceutical SOPs?

The reviewer set should reflect the SOP’s content, risk and applicable quality-system requirements.

It may include a process owner, technical SME, document owner, Quality and other specialist functions such as Regulatory Affairs or validation where relevant.

Not every SOP requires every possible reviewer.

The objective is to include the people needed to confirm accuracy, control and implementation readiness.

How can risk-based review improve pharma documentation?

Risk-based review allows organizations to apply more effort and formality to higher-risk content while avoiding unnecessary review depth for lower-risk changes.

ICH Q9(R1) explicitly states that quality-risk-management effort, formality and documentation should be commensurate with risk.

The same principle can help teams allocate review capacity more intelligently.

Risk-based review should still operate within the organization’s approved quality system and applicable requirements.

Can AI reduce pharmaceutical document review workload?

AI can assist with mechanical checks such as terminology consistency, formatting, duplicated text or possible readability issues.

It can reduce low-value work before human reviewers begin their regulated or technical assessment.

AI should not replace qualified judgment on scientific, quality or compliance decisions.

Bárd Global can support AI-ready documentation workflows while internal experts retain responsibility for controlled approvals.

Protect reviewer attention for the decisions that matter

Pharmaceutical documentation review works best when reviewer attention is treated as a limited quality resource.

The aim is not to remove necessary review. It is to stop using specialist time on avoidable formatting issues, repeated terminology debates and sections that have not materially changed.

Clear reviewer roles, stronger first drafts, risk-based review depth and disciplined comment resolution can reduce review fatigue while making important issues easier to see.

When the process is designed well, fewer comments can produce a stronger document because the comments that remain are focused on accuracy, risk and controlled implementation.

If your organization needs support improving pharmaceutical documentation review, SOP workflows or regulated documentation governance, contact Bárd Global.